Company / Book Value per Share
PTC Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$2.642
FY2025
5-year range
-$14.504 / $8.525
FY2021-FY2025
Trend
+81.8%
vs FY2024
Sector context
#204 of 209
Health Care
What the data says
Among 209 Health Care companies, PTC Therapeutics, Inc. is in the bottom 2% for book value per share. Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching -$2.642.
Based on SEC 10-K filings.
-$2.642 in FY2025.
Improved from -$11.197 to -$2.642 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 209This company -$2.642 Sector average $215.686
▼
-101.2% below sector average
Key checks
Key Insights
- In FY2025, book value per share increased 81.8% year-over-year.
- Ranks #204 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2019.
- Lowest book value per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.642 | +81.8% |
| FY2024 | -$14.504 | -29.5% |
| FY2023 | -$11.197 | -264.5% |
| FY2022 | $6.805 | -20.2% |
| FY2021 | $8.525 | +50.5% |
| FY2020 | $5.663 | -43.9% |
| FY2019 | $10.097 | +19.8% |
| FY2018 | $8.428 | +84.1% |
| FY2017 | $4.578 | +29.9% |
| FY2016 | $3.526 | -48.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026